• building

    Modern and spacious laboratories

  • Staff

    MOMA group 2017

  • Blood Samples

    Processing of blood samples

  • entrance
  • robot

    Robots automate workflows

  • 3130

    Loading samples for DNA sequencing

  • polymer
  • diagnostics

    DNA Diagnostics

  • miseq

    Genetic Diagnostics by NGS

  • genelist

    Molecular Diagnostics Gene Panels

  • robot NGS

    Robot automates NGS workflow 

  • bioinf

    Bioinformatic data analysis

  • cellline

    Our cell lines are STR-profiled

  • NGS Core Center

    NGS Core Center since 2012

  • ihc
  • ihc slice

    Immunohistochemistry detects proteins in tissue

  • Identicell

    STR-profiling of cell lines

  • cell culture

    Cell culture

  • cancer cells

    Colon adenocarcinoma cells

  • fluomic

    Fluorescence microscopy

  • samples

    Traceability is important for quality assurance

  • MOMA2009

About MOMA

The Department of Molecular Medicine (MOMA) is part of Aarhus University Hospital, and is associated with the Institute for Clinical Medicine at Aarhus University.

MOMA was established in 2008 at the Science Center Skejby, nearby the hospital.

From March 2018 MOMA is part of and managed by the Department of Clinical Biochemistry at Aarhus University Hospital.

You can find more information about the department at moma.auh.dk (Danish) or at  https://www.en.auh.dk/departments/department-of-molecular-medicine-moma/ (English).

 

The department has two main activities:

Molecular diagnostic service for national and international hospitals

Molecular clinical research, mainly in cancer

MOMA is accredited by DANAK/ILAC by the international laboratory standard DS/EN ISO 15189:2013 for medical examination - genetics. 

Our staff is counting more than 90 members including six professors, consultants, doctors, molecular biologists, researchers, bioinformaticians, medical technologists and students.
MOMA collaborates with leading laboratories worldwide especially in clinical translational studies. 

MOMA has over time expanded its technological facilities currently housing a wide range of state of the art equipment.
Substantial research fundings are received from The Danish Cancer Society, The Innovation Fund Denmark , The Lundbeck FoundationThe Independent Research Fund Danmark, Novo Nordisk Foundation and many other funds. 

 


Services

 

NGS Core Center
Genetic Analysis
 
Cell Line Authentication
 
NormFinder software

Current Research Network and Large Projects

DCCC Danish circulating tumor DNA network (DCCC ctDNA) (2019-)

NorDCaP - Nordic Implementation of Personalised Prostate Cancer Diagnostics (2019-)

PRIMA - Early and accurate detection of prostate cancer in general practice (2018-)

IMPROVE - Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)

IMPROVE-IT - Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer

"Individualized monitoring of cancer by deep sequencing of circulating tumor DNA in patients with advanced bladder cancer "(2017-)

PROCARIS - A new strategy to prevent overdiagnosis and overtreatment of non-aggressive prostate cancer in the aging male population (2016-)

PAGER - Analyzis of personal genomic rearrangements for surveillance of patients with bladder cancer (2013-)

OPRA - Oncology Precision Medicine Project Aarhus (2017-)

NEXT - Danish study of personalised cancer therapy based on tumor genetics (2017-)

""Early detection of recurrence and more curative therapy for colon cancer patients" (2016-2020)

PanCancer Analysis of Whole Genomes (PCAWG) Project (2015-)

Long non-coding RNAs as biomarkers and novel drivers of human bladder cancer (2014-)

Research Groups at MOMA

Bladder Cancer Group (Lars Dyrskjøt)

Colon Cancer Group (Claus Lindbjerg)

Prostate Cancer Group (Karina Dalsgaard Sørensen)

Medical Research Group (Claus Gravholt)

Bioinformatics Groups: